Week Ending September 12, 2022

Accessible, Nonstigmatizing Care Clinic Had Better Hepatitis C Outcomes
“Injection drug users who received accessible care treatment at a syringe service program were almost 3 times as likely to complete their hepatitis C treatment than people who received usual care.”

Hepatitis: The silent epidemic
“Hepatitis is liver inflammation caused by viruses, drugs, alcohol, toxins, genetic disorders, or an overactive immune system. Hepatitis can flare up suddenly (acute) and then goes away, or a long-term condition (chronic) produces subtle symptoms and progressive liver damage.”

Can We Eliminate Hepatitis C?
“WHO and CDC have laid out some ambitious goals for the treatment of hepatitis C, and HCV co-discoverer and vaccine developer Micheal Houghton, PhD, offers some insights and commentary on whether he feels it is realistic to consider the eradication of this stubborn and subtle virus.”

Bridging Science and Education Together to Eliminate Hepatitis C
“The Liver Health Initiative’s Thelma King Thiel, and HCV co-discoverer and vaccine developer Michael Houghton, PhD, are a “Dynamic Duo” that are working together to bring about an end to this virus.”

Viral Hepatitis C Load Increases Risk of Mother-to-Child Transmission
“Pregnant women with higher viral loads of hepatitis C virus (HCV) are at an increased risk of transmitting the virus to their offspring.”